Serologic association between human papillomavirus type 16 infection and esophageal cancer in Shaanxi Province, China

Journal of the National Cancer Institute

Volumn 88, Issue 20, 1996, Pages 1467-1471

  Han, Chenglong ^a   Qiao, Guibin ^b   Hubbert, Nancy L ^a   Li, Liangshou ^b   Sun, Changsheng ^b   Wang, Yan ^b   Yan, Mingxiao ^b   Xu, Dezhong ^b   Li, Yuangui ^b   Lowy, Douglas R ^a   Schiller, John T ^a,c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIBODY;

ADULT; ARTICLE; CASE CONTROL STUDY; CHINA; CONTROLLED STUDY; CROSS REACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; ESOPHAGUS CANCER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; VERRUCA VULGARIS; VIRUS PARTICLE; WART VIRUS;

ANTIBODIES, VIRAL; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CHINA; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; TUMOR VIRUS INFECTIONS;

EID: 10244257672     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/88.20.1467     Document Type: Article

References (25)

1. Day NE, Varghese C. Oesophageal cancer. Cancer Surv 1994;20:43-54.
2. Flood WA, Forastiere AA. Esophageal cancer. Curr Opin Oncol 1995; 7:381-6.
3. Li JY. Epidemiology of esophageal cancer in China. Natl Cancer Inst Monogr 1982;62:113-20.
4. Day NE, Munoz N. Cancer of the esophagus. In: Scottenfeld D, Fraumeni JF Jr, editors. Cancer epidemiology and prevention. Philadelphia: Saunders, 1982:596-623.
5. Craddock VM. Cancer of esophagus: approaches to the etiology. Cambridge: Cambridge Univ Press, 1993.
6. Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International Biological Study on Cervical Cancer (IBSCC) Study Group [see comment citation in Medline]. J Natl Cancer Inst 1995; 87:796-802.
7. Winkler B, Capo V, Reumann W, Ma A, La Porta R, Reilly S, et al. Human papillomavirus infection of the esophagus. A clinicopathologic study with demonstration of papillomavirus antigen by the immunoperoxidase technique. Cancer 1985;55:149-55.
8. Hille JJ, Margolius KA, Markowitz S, Isaacson C. Human papillomavirus infection related to oesophageal carcinoma in black South Africans. A preliminary study. S Afr Med J 1986;69:417-20.
9. Kulski J. Demeter T, Sterrett GF, Shilkin KB. Human papilloma virus DNA in oesophageal carcinoma [letter]. Lancet 1986;2:683-4.
10. Chang F, Syrjanen S, Shen Q, Wang L, Syrjanen K. Screening for human papillomavirus infections in esophageal squamous cell carcinomas by in situ hybridization. Cancer 1993;72:2525-30.
11. Cooper K, Taylor L, Govind S. Human papillomavirus DNA in oesophageal carcinomas in South Africa. J Pathol 1995;175:273-7.
12. Togawa K, Jaskiewicz K, Takahashi H, Meltzer SJ, Rustgi AK. Human papillomavirus DNA in esophagus squamous cell carcinoma. Gastroenterology 1994;107:128-36.
13. Akutsu N, Shirasawa H, Nakano K, Tanzawa H, Asano T, Kobayashi S, et al. Rare association of human papillomavirus DNA with esophageal cancer in Japan. J Infect Dis 1995;171:425-8.
14. Benamouzig R, Jullian E, Chang F, Robaskiewicz M, Flejou JF, Raoul JL, et al. Absence of human papillomavirus DNA detected by polymerase chain reaction in French patients with esophageal carcinoma. Gastroenterology 1995;109:1876-81.
15. van Rensburg EJ, Venter EH, Simson IW. Human papillomavirus DNA in aerodigestive squamous carcinomas demonstrated by means of in situ hybridisation. S Afr Med J 1993;83:516-8.
16. Campo MS, Moar MH, Sartirana ML, Kennedy IM, Jarrett WF. The presence of bovine papillomavirus type 4 DNA is not required foi the progression to, or the maintenance of, the malignant state in cancers of the alimentary canal in cattle. EMBO J 1985;4:1819-25.
17. Kirnbauer R, Hubbert NL, Wheeler CM, Becker TM, Lowy DR, Schiller JT. A virus-like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16 [see comment citation in Medline]. J Natl Cancer Inst 1994; 86:494-9.
18. Dillner J, Knekt P, Schiller JT, Hakulinen T. Prospective seroepidemiological evidence that human papillomavirus type 16 infection is a risk factor for oesophageal squamous cell carcinoma. BMJ 1995;311:1346.
19. Han CL. A causative factors study of esophageal cancer among city inhabitants in Xian: the role of smoking and drinking (in Chinese). Chung Hua Liu Hsing Ping Hsueh Tsa Chih 1988;9:12-5.
20. Wideroff L, Schiffman MH, Nonnenmacher B, Hubbert N, Kirnbauer R, Greer CE, et al. Evaluation of seroreactivity to human papillomavirus type 16 virus-like particles in an incident case-control study of cervical neoplasia. J Infect Dis 1995;172:1425-30.
21. Nonnenmacher B, Hubbert NL, Kirnbauer R, Shah KV, Munoz N, Bosch FX, et al. Serologic response to human papillomavirus type 16 (HPV-16) virus-like particles in HPV-16 DNA-positive invasive cervical cancer and cervical intraepithelial neoplasia grade III patients and controls from Colombia and Spain. J Infect Dis 1995;172:19-24.
22. Editorial Committee for the Atlas of the Cancer Mortality in the PRC. Atlas of the cancer mortality in the PRC. Shanghai: China Map Press, 1979.
23. Pakarian F, Kaye J, Cason J, Kell B, Jewers R, Derias NW, et al. Cancer associated human papillomaviruses: perinatal transmission and persistence. Br J Obstet Gynaecol 1994;101:514-7.
24. Shah K, Kashima H, Polk BF, Shah F, Abbey H, Abramson A. Rarity of cesarean delivery in cases of juvenile-onset respiratory papillomatosis. Obstet Gynecol 1986;68:795-9.
25. Schiller JT, Okun MM. Papillomavirus vaccines: current status and future prospects. In: James WD, Cockerell CJ, Dzubow LM, Palier AS, Yancey KB, editors. Advances in dermatology. Vol 11. St. Louis (MO): Mosby, 1996:355-80.